Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
rexmyelocel-T
- Development stage
- Phase 3
- Lead developer
- Alaya.bio
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intra-arterial
01
Overview
Rexmyelocel-T (REX-001) is an autologous cell therapy consisting of bone marrow-derived mononuclear cells (BMMNCs) harvested from the patient's own bone marrow. Developed by Rexgenero Limited, it is an advanced therapy medicinal product (ATMP) designed to treat Critical Limb Ischemia (CLI), particularly in patients with type 2 diabetes mellitus. The therapeutic mechanism involves the migration of these mononuclear cells to ischemic tissue, where they promote angiogenesis (the formation of new blood vessels) and provide support to the existing vasculature. It is administered via a single intra-arterial infusion. Rexmyelocel-T has been evaluated in Phase III pivotal trials targeting patients at Rutherford Categories 4 and 5.
- Brand names
- REX-001REX001REX 001
- Other names
- bone marrow-derived mononuclear cellsBMMNCs
Beyond the preview
Go deeper on rexmyelocel-T.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on rexmyelocel-T.